Expanding access to treatment of Opioid Use Disorder through LAIB | Kyneton
November 13 @ 6:00 pm - 8:00 pm
Presented by Orticare, Grampians Loddon Mallee Pharmacotherapy Network
In this clinical network meeting, Professor Ed Ogden will explore strategies for expanding access to opioid use disorder treatment through the use of long-acting injectable buprenorphine.
With a focus on enhancing patient outcomes and addressing barriers to care, Professor Ogden will provide insights into the latest research and practical applications of this treatment modality. This meeting is an excellent opportunity for healthcare professionals to gain a deeper understanding of how long-acting buprenorphine can improve engagement and retention in treatment programs.
Audience: Healthcare professionals